News & Perspective

Apr 28, 2009

Apr 28, 2009

SWINE FLU BREAKING NEWS

 

Editor's note: Today we are launching a daily digest of the latest developments concerning the swine influenza H1N1 virus. This digest will be updated more than once a day as news developments dictate.

Apr 29, 2009

Apr 29, 2009

May 01, 2009

May 01, 2009

Path to swine flu vaccine has major hurdles

(CIDRAP News) – National and international health authorities said today that they have begun the first steps in manufacturing a vaccine against the novel H1N1 swine influenza, though they appeared to disagree over whether full-scale manufacturing will move forward.

May 04, 2009

May 04, 2009

SWINE FLU BREAKING NEWS: Global case count, US cases widespread, pigs infected, Mexico sees improvement, concern about hoarding

Twenty countries were reporting a total of 985 confirmed cases of influenza A/H1N1 (swine flu) as of early today, the World Health Organization (WHO) reported. Mexico has reported 590 cases with 25 deaths. The WHO total includes yesterday's US report of 226 cases in 30 states, with one death. Other countries with more than 10 cases were Canada, 85; Spain, 40; and the United Kingdom, 15. [WHO statement]

May 06, 2009

May 06, 2009

FDA approves new vaccine facility

(CIDRAP News) –The US Food and Drug Administration (FDA) today announced approval of a new influenza vaccine manufacturing facility in Pennsylvania that could be used to produce a vaccine against the novel influenza H1N1 (swine flu) virus.

Jun 23, 2009

Jun 23, 2009

Firm wins HHS contract for new flu vaccine technology

(CIDRAP News) – The US government has granted Protein Sciences Corp. (PSC) of Meriden, Conn., a $35 million contract to develop its technique for making influenza vaccines by growing flu virus proteins in insect cells, an approach said to be faster than traditional methods.

Aug 06, 2009

Aug 06, 2009

WHO says H1N1 vaccine process won't sacrifice safety

(CIDRAP News) – The World Health Organization (WHO) said today that the fast-tracking of vaccines for pandemic H1N1 influenza won't compromise safety, while acknowledging that clinical data will be limited when the first doses are administered.

Pages

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»